4//SEC Filing
DiBiase Mary 4
Accession 0001628280-22-029265
CIK 0001501697other
Filed
Nov 8, 7:00 PM ET
Accepted
Nov 9, 4:23 PM ET
Size
5.6 KB
Accession
0001628280-22-029265
Insider Transaction Report
Form 4
DiBiase Mary
Chief Operating Officer
Transactions
- Award
Stock Appreciation Right
2022-11-07+1,350,000→ 1,350,000 totalExercise: $1.80Exp: 2032-11-07→ Common Stock (1,350,000 underlying)
Footnotes (1)
- [F1]The Stock Appreciation Right will vest and become exercisable in equal annual installments (rounding down to the nearest whole share, except for the last installment) on the first, second, and third anniversaries of November 7, 2022, subject to the Reporting Person remaining an employee of the Issuer through and including each applicable vesting date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001880179
Filing Metadata
- Form type
- 4
- Filed
- Nov 8, 7:00 PM ET
- Accepted
- Nov 9, 4:23 PM ET
- Size
- 5.6 KB